Pet Food Recall Impacts Idexx’s Revenue

Idexx Laboratories Inc.’s revenues have been positively effected by the pet food recall.

Idexx Laboratories Inc.’s companion animal division reported that its revenue for the first quarter ended March 31 and increased 24 percent to $173.4 million from $139.4 million in the year-ago period.

The recent pet food recalls have had a positive effect on Idexx’s reference laboratories and instrument consumables businesses, according to Jonathan Ayers, chairman and chief executive officer.

“Particularly strong revenue growth in [these businesses] resulted in part from the well-publicized pet food recalls during the quarter, which we believe caused an unusually high number of pet visits to the veterinary clinic for exams that included diagnostic testing,” he said.

Overall, the company reported net income of $21 million on revenue of $211.2 million for its first quarter, compared to net income of $18.3 million on revenue of $168.2 million in the year-ago period.

Idexx also provided revised guidance for the full year of 2007. Idexx expects revenue to be $890 million to $897 million, updated from $875 million to $887 million.


Leave a Comment


Your email address will not be published. Required fields are marked *



Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.